In a previous paper (1), it was shown that strains of pneumococci producing a capsule of soluble polysaccharide (C~) 1 related chemically and immunologically to the C or cell-wall polysaccharide of pneumococcus arise b y spontaneous mutation and can be isolated readily from several noncapsulated variants of this organism. Vaccines of the Cs mutants are highly antigenic in rabbits, giving rise to antisera of high titer which serve as useful tools for the study of the properties not only of the Cs capsular polysaccharides, but also of the closely related C polysaccharides.
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In a previous paper (1) , it was shown that strains of pneumococci producing a capsule of soluble polysaccharide (C~) 1 related chemically and immunologically to the C or cell-wall polysaccharide of pneumococcus arise b y spontaneous mutation and can be isolated readily from several noncapsulated variants of this organism. Vaccines of the Cs mutants are highly antigenic in rabbits, giving rise to antisera of high titer which serve as useful tools for the study of the properties not only of the Cs capsular polysaccharides, but also of the closely related C polysaccharides.
Although pneumococcal C polysaccharide was first described by Tillett et al. as early as 1930 (2, 3) , detailed knowledge of the cell wall of pneumococcus has lagged behind that of many other Gram-positive organisms. Liu and Gotschlich (4-6) proposed that the C polysaccharide of strain R36A, a noncapsulated variant of pneumococcus Type II, is a polymer with a repeating unit composed of beta-N-acetyl-DgMactosamine-l-phosphate joined through its phosphate group to the 6-hydroxyl group of the next unit, and that this teichoic acid is cross-linked to a mucopeptide by phosphodiester bonds with muramic acid. Exception to this structure was taken by Brundish and Baddiley (7) because it did not contain ribitol, diaminotrideoxyhexose, or choline (8) . In addition, the proposed structure did not account for the well-known lability of C polysaccharide to nitrous acid. Brundish and Baddiley extracted noncapsulated pneumococci with 10% trichloroacetic acid; after purification they isolated a substance, the structure of which is consistent with a repeating unit, N-acetyl-galactosaminyl-glucosyl-N-acetyldiaminotrideoxyhexosyl-ribitol-5-phosphate, joined through its phosphate group to either position 3 or 4 of N-acetylgalactosamine of an adjacent repeating unit. To this backbone 1 mole of choline phosphate is added to the ribitol to complete the rather complex teichoic acid. The structure proposed by Brundish and Baddiley was concurred in by Mosser and Tomasz (9) , who developed a model for the partial structure of the pneumococcal cell wall. Their model consists o[ a teichoic acid similar to that described by Brundish and Baddiley to which is attached a peptidoglycan similar to that commonly found in other Gram-positive bacteria as suggested by Liu and Gotschlich (4) . The peptidoglycan appears to be cross-linked to form dimers (or trimers); this property places it among the Type III cell wall mucopepfides according to the classification of Ghuysen (10) .
This report describes the isolation of the C~ capsular polymers and of the C polysaccharides from Cs capsulated and from noncapsulated strains of pneumococcus and demonstrates that, despite marked similarities, differences exist not only between the C~ and C polysaccharides of a single strain, but also among the Cs polysaccharides and the C polysaccharides of different strains. The results suggest that these differences are attributable to variations in the mucopepfide portions of the molecules, and that the extensive cross-reactions are related largely to the teichoic acid moieties thereof in agreement with the findings of Brundish and Baddiley, who showed that the teichoic acids from several strains of pneumococcus were chemically identical.
Materials and Methods

Nomenclature of Pneumococcal Variants and Strains of Pneumococcus
Employed.--The nomenclature of pneumoeoccal variants and of the strains used are described in the preceding paper (1) except as noted below:
S-h: a noncapsulated mutant of pneumococcus derived from the Type I strain ID. S-II1: a noncapsulated mutant of the Type II strain, D39S, described previously as strain R36NC. S-ih: a noncapsulated mutant of pneumocoecus Type II derived from strain R36NC and described previously as strain R630. Growth of Organisms and Isolation of Polysaccharides.--Pneumococci were grown overnight in fresh beef heart infusion broth supplemented with 1% Neopeptone (Difco Laboratories, Inc., Detroit, Mich.). Glucose was then added to a final concentration of 1%, and incubation of the culture was continued with periodic neutralization with 3 N NaOH of the lactic acid formed. At the end of the exponential phase of growth, the bacterial cells were harvested by centrifugation and allowed to autolyze in 30 ml of 5% sodium acetate at 37°C for 18 hr. The insoluble cellular debris was removed by centrifugation and the supernatant fluid was either dialyzed and lyophilized, or the polysaccharides were precipitated by the addition of 3 volumes of ethanol. Protein was removed from the soluble nondialyzable material by shaking with chloroform-octanol (Sevag method), after which procedure the supernatant was fractionated with ethanol. After the addition of 0.8 volume of ethanol, a fraction is precipitated which is usually of low specific activity when measured by its precipitability with appropriate antisera. The fraction precipitating between 44 and 55% ethanol (0,8-1.2 volumes) is mainly Cs capsular polysaccharide, whereas that precipitating between 55 and 75% ethanol (1.2-3.0 volumes) is mainly C polysaccharide.
The C and C s polysaccharides were purified further by gel filtration on Sephadex G-200 in 0.2 N acetic acid (6) . Effluent fractions were assayed by measuring their weights after lyophilization and their reactivity with antiserum. Preparations of teichoic acid were made according to the procedure of Brundish and Baddiley (7) . Teichoic acid is extracted from whole pneumococcal ce]]s with 10% trichloroacetic acid (TCA). When wild-type capsulated cells are treated in this fashion, the teichoic acid obtained is presumably that portion of the C polysaccharide which is attached to the mucopeptide of the intact cell wall. When Cs capsulated strains are employed, the material derived from treatment with TCA represents the teichoic acid moieties of both the C and C~ polysaccharides of such strains.
Preparation of A ntisera and Immunologic Techniques.--Antisera were prepared in rabbits.
50/~g bacterial nitrogen in the form of formalin-treated log-phase pneumococci which had been heated at 60°C for 30 min was injected intravenously three to four times weekly for 2 wk, and the animals were bled by cardiac puncture 6 days after the last injection. This schedule was repeated for eight or more courses, antisera of high titer being obtained usually after two to four such courses of immunization. Ouchterlony analysis of the various polysaccharides was performed in 1% Difco purified agar dissolved in Gelman barbital buffer (Gelman Instrument Co., Ann Arbor, Mich.), 0.05 ionic strength, pH 8.6. Concentrations of antigen were 1.0 mg/ml. Wells were made with an LKB die (LKB Instrument Co., Washington, D.C.) and were of approximately 8 ttl volumes.
Quantitative precipitin analysis was performed in the manner described previously (1) with the ninhydrin technique (11) .
Preparation of DNA and Techniques of Transformation.--The methods used were those described by MacLeod and Krauss (12) and by Bernheimer, Wermundsen, and Austrian (13) .
RE SULTS
Isolation of C~ and C Polysaccharides from C, Capsular Mutants.--Supernatant
fluids from neutralized cultures of C~ pneumococcal mutants contain C~ polysaccharide precipitable by 50% ethanol, whereas similar fluids from cultures in which noncapsulated pneumococci have been grown do not contain appreciable quantities of such polymers. This difference provides a method, therefore, for obtaining Cs polysaccharide which is relatively free from C polysaccharide. Because many other substances are also precipitated from such complex culture fluids in the presence of 50 % ethanol, the final purification of the Ca polysaccharide is cumbersome. On the other hand, autolysates of bacterial cells after deproteinization contain 25-70% of C~ and C polysaccharides. The problem of purification, therefore, is largely one of separating Ca from C polysaccharide. Because capsular polysaccharides are, in general, polynalers of high molecular weight, whereas C polysaccharide from pneumococcal autolysates has been reported to ]lave a molecular weight as low as 26,400 (14) , separation of the two by fractionation with alcohol was attempted. As can be seen in Fig. 1 , the fraction of a deproteinized, dialyzed autolysate of the C~ pneumococcal strain S-H~C~, precipitated with 33 % ethanol (0.5 volume), produces material of low specific activity in precipitating rabbit antibody to the same strain. The fraction precipitated by 33-44% ethanol (0.5-0.8 volume) is somewhat more active but still much less so than the fraction precipitated by concentrations of ethanol between 44 and 55 % (0.8-1.2 volumes). The high specific activity of the fraction precipitated by 55-67% (1.2-2.0 volumes) ethanol was anticipated because this fraction is the one that yielded C polysaccharide in earlier studies. As an initial step in purification, therefore, deproteinized, dialyzed autolysates of C~ pneumococcal strains were fractionated with ethanol by employing the following concentrations: 0-44% (0.8 volume), 44-55% (0.8-1.2 volumes), and 55-67 % (1.2-2.0 volumes), the last two fractions containing the C~ and C polysaccharides respectively. As can be seen in Fig. 2 , right and left, unfractionated lysates obtained from noncapsulated organisms give single bands of precipitate in agar gels with antibody to a Cs capsular mutant, whereas similar preparations from Ca mutants yield two bands with the same antiserum. Fractional precipitation with ethanol by the procedure cited above separates the faster moving inner band of C polysaccharide from the slower moving outer band of Cs polysaccharide.
A study of the quantitative distribution of the C polysaccharides from pneumococcal strains S-I2, S-II2, and S-III4 and of the C., and C polysaccharides from their respective spontaneous Cs mutants was made. After isolation of the Cs mutants, it was noted that the sizes of the capsules of strains S-m4C~ and S-vHItC~, as observed by the capsular precipitin reaction, were significantly larger than those of strains S-I2Cs and S-II~C~. It was expected, therefore, that the 0.8-1.2 volumes ethanol fractions would represent a larger percentage of the total polysaccharide isolated from the strains with the larger capsules than from the strains with smaller ones. The realization of this expectation is shown in the results recorded in Table I whereas only 6-13 % of the total is found in the corresponding fraction from strains S-,~C~ and S-H1C~. It should be noted, however, that the relative amount of serologically reactive polysaccharide precipitated from the 0.8-1.2 volumes ethanol fraction of lysates of strain S-~2 was significantly higher than that from comparable fractions of lysates of other noncapsulated strains, although fractions of lysates of strain S-x 2 showed only a single band of precipitate in precipitin reactions in agar gels (Fig. 2 right) .
Purification of C.~ and C Polysaccharides by Gel Filtration.--Preparations of
polysaccharides obtained by fractionation with ethanol were purified further by filtration through Sephadex G-200 or, in some cases, through Sephadex G-150. Fig. 3 shows the results of such a fractionation. Material precipitated by the addition of 0.8 volume ethanol to an autolysate of strain S-H1C~ (Fig.  3 a) contains an extremely heterogeneous population of molecular sizes extend-ing from that of the excluded material (peak about 100 ml) to those of very small size. On the other hand, material precipitating between 0.8-1.2 volumes ethanol (Fig. 3 3) consists primarily of material of large molecular weight (peak at 130-165 ml, 57 rag) with only small amounts of material (22 nag) being eluted from the column in the effluent fraction from 165-330 ml. The material precipitating between 1.2 and 3.0 volumes ethanol (Fig. 3 c) eluted in a skewed peak, but one, the maximum of which was at 300 ml of effluent, and clearly indicative of material of smaller molecular size than that in the 0.8-1.2 volumes ethanol precipitate. Even very small columns of Sephadex G-200, 44 X 0.9 cm, can be used to purify small amounts (5-50 nag) of material from pneumococcal autolysates. In the preceding paper (1), it was reported that absorption of an antiserum prepared against a noncapsulated pneumococcus with the capsular polysaccharide of a Cs mutant removed 95 % or Inore of the antibody precipitable by C polysaccharide. This finding demonstrated the close immunological relationship between C and Cs polysaccharides. With certain antisera, however, significant antigenic differences between these polysaccharides were noticed by precipitin reactions in agar gels (Fig. 4) . Differences were found to exist between the C and Cs polysaccharide of a single pneumococcal strain and between the C polysaccharide of the C~ mutant and that of the parent pneumococcal strain from which that mutant was derived. A somewhat different picture is presented by antiserum to another C~ mutant. Serum 66819 prepared against strain S-II2Cs reacted equally well with the C~ polysaccharide of the autologous strain and with the C polysaccharide of the parental strain S-H2, each precipitating 16-18 vg of antibody nitrogen from an equal volume of antiserum (Fig. 6) . Preparations of teichoic acid from each of strains S-H2Cs, S-vm~Cs, and S-wH~ precipitate over 80% of the precipitable antibody. This result indicates that serum 66819 contains antibody directed chiefly against a component common to all these polysaccharides, i.e., teichoic acid. Consistent differences in the antibody responses to vaccines of these two strains, S-vHI~Cs and S-I~2C~, were observed in several rabbits and appear to reflect configurational and immunological differences in their Cs polysaccharides. employed failed to produce potent antisera when vaccines of noncapsulated strains were used. Resumption of immunization with noncapsulated strains after a rest period of 3 months, however, was followed by good responses. Table II presents the data from quantitative precipitin reactions obtained with sera from sequential bleedings of rabbit 18 immunized with strain S-wnlMter 4 months of immunization, the titer of anti-C antibody in bleeding 12 was high enough to analyze by the precipitin technique. In the next month, the titer rose to 430 ug antibody nitrogen/ml, but, thereafter, it fell progressively despite continuous immunization. Immunization was discontinued for 3 months, and when it was resumed, the titer of antibody rose rapidly again, remained high for 2 months, and then fell progressively.
PNEUMOCOCCAL
Cs POLYSACCHARID]~. II Antiserum from rabbit 18 was of unusual interest because it was capable of discriminating among the C polysaccharides of several pneumococcal strains. Fig. 7 shows the precipitin curves obtained when C polysaccharides from four noncapsulated strains, S-,~, S-H2, S-m~, and S-vm, react with bleeding 15 from this rabbit, (serum 181~). C polysaccharide from strain S-, 2 in amounts ranging up to 15 ~g failed to precipitate any antibody nitrogen from 50 ~1 of serum 18~5, whereas 2.5-5 ~g of C polysaccharide from strains S-Hv S-m4, and S-viii precipitated 9-10 ug of antibody nitrogen. C polysaccharide from strain S-~ 2 was shown to be an effective antigen, however, precipitating the same amount of antibody from antiserum to strain S-n2C~ as the C polysaccharide of strain S-ii 2. Fig. 8 depicts the data from quantitative precipitin tests obtained when the C polysaccharides prepared from the corresponding Cs strains, S-I2C~, S-II~C~, S-m,Cs, and S-wH1C~ react with antiserum 18eo to strain S-will. It can be seen that the C polysaccharides from strains S-~2C.~ and S-m4C~ react with antiserum 1820 to precipitate between 9 and 10 #g antibody nitrogen from 10 ~1 of serum. In sharp contrast, C polysaccharides from strains S-~2C~ and S-vm~C~ precipitate only 1-2 #g antibody nitrogen. These latter preparations precipi-rated larger amounts of antibody nitrogen from other antisera, showing thereby that their poor reactivity with serum 1820 resulted from its low reactivity with the specific determinants of these polysaccharides. Analogous results were obtained when serum 1820 reacted with C~ polysaccharides of these four strains.
The teichoic acid prepared from strain S-vm~ precipitated less than 2 gg antibody nitrogen from 10 gl of serum 1819 from which 10 gg antibody nitrogen is precipitable by the autologous C polysaccharide (Fig. 9) . This antiserum appears to be directed, therefore, against determinants other than the teichoic acid portion of C polysaccharide. Use was made of the fact that C polysaccharide from strain S-vim precipitated antibody from serum 1820, but that C polysaccharides from strains S-I2C8 and S-vmlC8 did not. DNA from each of the latter two strains of pneumococcus was used to transform strain S-vml to the Cs capsulated state. After isolation of the C~ capsular transformants, C and Cs polysaccharides were recovered and tested for their ability to react with serum 18. It was found in all cases examined that their ability to react with serum 18 was similar to that of the recipient strain, S-vine, i.e., the C polysaccharide reacted with serum 18 indicating that transformation to the Cs capsular state did not modify the mucopeptide portion of the C polysaccharide of the recipient strain in such a way as to change its reactivity with this antiserum. Data listing the reactions of the C polysaccharides of these strains before and after transformation are shown in Table III .
DISCUSSION
In an earlier publication, some of the properties of mutant strains of pneumococcus producing a capsule of C-like (Cs) polysaccharide were described (1). In the present report, the separation of the C, capsular polysaccharide from the C or cell wall polysaccharide has been presented in greater detail. Ca polysaccharide can be recovered from the supernatant fluid of cultures of suitable strains relatively free of C polysaccharide by precipitation with 1 volume of ethanol. It can be separated also from the C polysaccharide in autolysates of the same organisms by appropriate chemical or physical techniques. Purification of Cs polysaccharides from cell lysates entails deproteinization, fractional precipitation, and gel filtration. The precipitation of C~ polysaccharide with lower concentrations of ethanol than are required to precipitate C polysac-charide, the earlier elution of the former from mixtures filtered through gels, and the relative position of the two polysaccharides in immunoprecipitates in agar gels all point to the higher molecular weight of the Cs polysaccharide. Immunologic analysis of the C and Cs polysaccharides from a variety of pneumococcal strains has brought to light a number of findings regarding their properties. Contrary to the expectation that the C polysaccharides of diverse pneumococcal strains would be identical, differences among them have been found. Such differences have been discovered to exist between the C polysac- Cs, X. charides of wild-type capsulated strains by means of selected sera and appear to reside in the mucopeptide moiety of the C polysaccharide (Table IV) . The C polysaccharide of a Type I strain, ID, reacts with an antiserum to the C polysaccharide of the noncapsulated strain S-v,u, whereas that of the Type II strain, II D39S, and that of the Type VIII strain, VIII H, fail to do so. Analogous differences exist among noncapsulated variants isolated from each of these three strains. Of additional interest is the nonidentity of the C polysaccharides of independently isolated noncapsnlated mutants of a single capsulated strain. Each member of pairs of such noncapsulated variants isolated from cultures of pneumococci of three capsular types has been shown to have a C polysaccharide differing in immunologic behavior from that of the other. It would appear, therefore, that mutations affecting the structure of the cell wall polysaccharide of pneumococcus are not uncommon. It is of additional interest that no correlation between the competence of noncapsulated strains of pneumococcus in transformation reactions and the immunologic reactivity of their C polysaccharides has been observed.
When strains of noncapsulated pneumococci of diverse origins mutate to form capsules of C~ polysaccharide, the C polysaccharides of five such C~ capsular mutants have been found to retain the parental pattern of reactivity with antiserum to the C polysaccharide of strain S-w~i1. The single exception to this observation has been noted in C.~ mutants of strain S-w~h itself. The C polysaccharides of several independently isolated Cs variants of strain S-viih have been shown to differ consistently in their reactivity with antiserum to strain S-will from that of the parental noncapsulated strain. It would appear, therefore, that mutation(s) of strain S-vnIl to the C~ capsular state are complex, affecting not only the production of C~ capsular material but also the structure of the cell wall polysaccharide.
When the C, polysaccharides of the spontaneous mutants of the noncapsu-lated strains of pneumococci included in Table IV are examined with antiserum to the noncapsulated strain S-wn~, it is observed that the immunologic reactions of the C~ polysaccharides are similar to those of the C polysaccharides of the same strains and, with the exception of strain S-wmC~ noted above, similar to those of the C polysaccharides of the noncapsulated strains from which they were derived. It should be borne in mind, however, that serologic similarity of reactivity with a single antiserum does not imply chemical identity. As noted earlier, immunologic nonidentity can be demonstrated between the C and C~ polysaccharides of a single pneumococcal strain if the appropriate antiserum is used (Fig. 4) . When the C and C~ polysaccharides of pneumococcal transformants are examined with the antiserum to strain S-vml, the results of such studies indicate that both the isolated C and C~ polysaccharides of the transformant reflect the structural properties of the C polysaccharide of the recipient strain rather than those of the polysaccharides of the donor strain from which the DNA was obtained. Although this observation does not establish the chemical identity of the C and Cs polysaccharides of the transformant or the identity of its C polysaccharide with that of the strain employed as the recipient in the transformation, it is consistent with the concept that transformation affects especially the capacity to produce a capsule of C~ polysaccharide. The final significance of inferences such as these must await detailed chemical study of the structure of the several polysaccharides involved. It would appear from the immunologic data available, however, that the several differences among C and C~ polysaccharides described will reside in the mucopeptide moiety of the molecules rather than in the teichoic acid portions thereof. All preparations of teichoic acids from pneumococcal C and Cs polysaccharides examined have proved to be immnnologically identical.
Mutation affecting the structure of cell wall polysaccharides has been observed previously. McCarty and Lancefield (15) , and McCarty (16), have described variations in the chemical structure of the C polysaccharide of Group A streptococci which were related to alterations in the carbohydrate constituents of the molecule. Data from the immunologic study of the C and C~ polysaccharides of pneumococcus suggest that, in this organism, variations in the serologic reactivity of these compounds are more likely to result from differences residing in the mucopeptide portion of the molecule or in the region of its attachment to the teichoic acid moiety.
SUMMARY
Methods are described for the separation of the C or cell wall polysaccharide from the Cs or soluble C-like capsular polysaccharide of Cs pneumococcal strains. Immunologic analysis has shown that both the C and C~ polysaccharides of a variety of pneumococcal strains are heterogeneous and that the dissimilarities appear to reside in the mucopeptide portion of the molecule or in the region of its attachment to the telchoic acid moiety of the molecule rather than in the teichoic acid fraction. Differences of the type described have been observed in the C polysaccharides of wild-type capsulated strains of several types, in those of independently isolated noncapsulated
